Works matching IS 17568722 AND DT 2022 AND VI 15

Results: 188

miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01394-1
By:
- Cuttano, Roberto;
- Colangelo, Tommaso;
- Guarize, Juliana;
- Dama, Elisa;
- Cocomazzi, Maria Pia;
- Mazzarelli, Francesco;
- Melocchi, Valentina;
- Palumbo, Orazio;
- Marino, Elena;
- Belloni, Elena;
- Montani, Francesca;
- Vecchi, Manuela;
- Barberis, Massimo;
- Graziano, Paolo;
- Pasquier, Andrea;
- Sanz-Ortega, Julian;
- Montuenga, Luis M.;
- Carbonelli, Cristiano;
- Spaggiari, Lorenzo;
- Bianchi, Fabrizio
Publication type:
Article
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01395-0
By:
- Zhang, Guangbing;
- Guo, Cuiyu;
- Wang, Yan;
- Zhang, Xianda;
- Liu, Shuang;
- Qu, Wen;
- Chen, Chunxia;
- Yan, Lingli;
- Yang, Zhouning;
- Zhang, Zhixiong;
- Jiang, Xiaohua;
- Chen, Xiaofeng;
- Liu, Hong;
- Lai, Qinhuai;
- Wei, Xian;
- Lu, Ying;
- Zhao, Shengyan;
- Deng, Han;
- Wang, Yuxi;
- Yu, Lin
Publication type:
Article
A novel tRNA-derived fragment tRF-3022b modulates cell apoptosis and M2 macrophage polarization via binding to cytokines in colorectal cancer.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01388-z
By:
- Lu, Sicheng;
- Wei, Xiaoman;
- Tao, Lihuiping;
- Dong, Dan;
- Hu, Wenlong;
- Zhang, Qinchang;
- Tao, Yuquan;
- Yu, Chengtao;
- Sun, Dongdong;
- Cheng, Haibo
Publication type:
Article
Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.
Published in:
2022
By:
- Liu, Qian;
- Li, Anping;
- Yu, Shengnan;
- Qin, Shuang;
- Han, Na;
- Pestell, Richard G.;
- Han, Xinwei;
- Wu, Kongming
Publication type:
Correction Notice
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01379-0
By:
- Shah, Bijal D.;
- Ghobadi, Armin;
- Oluwole, Olalekan O.;
- Logan, Aaron C.;
- Boissel, Nicolas;
- Cassaday, Ryan D.;
- Leguay, Thibaut;
- Bishop, Michael R.;
- Topp, Max S.;
- Tzachanis, Dimitrios;
- O'Dwyer, Kristen M.;
- Arellano, Martha L.;
- Lin, Yi;
- Baer, Maria R.;
- Schiller, Gary J.;
- Park, Jae H.;
- Subklewe, Marion;
- Abedi, Mehrdad;
- Minnema, Monique C.;
- Wierda, William G.
Publication type:
Article
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01392-3
By:
- Tong, Xuhui;
- Tang, Rong;
- Xiao, Mingming;
- Xu, Jin;
- Wang, Wei;
- Zhang, Bo;
- Liu, Jiang;
- Yu, Xianjun;
- Shi, Si
Publication type:
Article
Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01391-4
By:
- Fu, Kai;
- Xie, Fachao;
- Wang, Fang;
- Fu, Liwu
Publication type:
Article
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01376-3
By:
- Caruso, Simona;
- De Angelis, Biagio;
- Del Bufalo, Francesca;
- Ciccone, Roselia;
- Donsante, Samantha;
- Volpe, Gabriele;
- Manni, Simona;
- Guercio, Marika;
- Pezzella, Michele;
- Iaffaldano, Laura;
- Silvestris, Domenico Alessandro;
- Sinibaldi, Matilde;
- Di Cecca, Stefano;
- Pitisci, Angela;
- Velardi, Enrico;
- Merli, Pietro;
- Algeri, Mattia;
- Lodi, Mariachiara;
- Paganelli, Valeria;
- Serafini, Marta
Publication type:
Article
Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01387-0
By:
- Jondreville, Ludovic;
- D'Aveni, Maud;
- Labussière-Wallet, Hélène;
- Le Bourgeois, Amandine;
- Villate, Alban;
- Berceanu, Ana;
- Bezsera, Silvia-Maria;
- Thiebaut, Anne;
- Boissard-Simonet, Marion;
- Legrand, Marlène;
- Cornillon, Jérôme;
- Rubio, Marie-Thérèse;
- Chevallier, Patrice;
- Nguyen, Stéphanie
Publication type:
Article
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01384-3
By:
- Tong, Yexin;
- Sun, Mingjun;
- Chen, Lingli;
- Wang, Yunzhi;
- Li, Yan;
- Li, Lingling;
- Zhang, Xuan;
- Cai, Yumeng;
- Qie, Jingbo;
- Pang, Yanrui;
- Xu, Ziyan;
- Zhao, Jiangyan;
- Zhang, Xiaolei;
- Liu, Yang;
- Tian, Sha;
- Qin, Zhaoyu;
- Feng, Jinwen;
- Zhang, Fan;
- Zhu, Jiajun;
- Xu, Yifan
Publication type:
Article
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01385-2
By:
- Yu, Jifeng;
- Li, Song;
- Chen, Dianze;
- Liu, Dandan;
- Guo, Huiqin;
- Yang, Chunmei;
- Zhang, Wei;
- Zhang, Li;
- Zhao, Gui;
- Tu, Xiaoping;
- Peng, Liang;
- Liu, Sijin;
- Bai, Xing;
- Song, Yongping;
- Jiang, Zhongxing;
- Zhang, Ruliang;
- Tian, Wenzhi
Publication type:
Article
hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01315-2
By:
- Su, Yan;
- Sun, Xueyan;
- Liu, Xiao;
- Qu, Qingyuan;
- Yang, Liping;
- Chen, Qi;
- Liu, Fengqi;
- Li, Yueying;
- Wang, Qianfei;
- Huang, Bo;
- Huang, Xiao-Jun;
- Zhang, Xiao-Hui
Publication type:
Article
Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemia.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01386-1
By:
- Muhowski, Elizabeth M.;
- Ravikrishnan, Janani;
- Gordon, Britten;
- Yu, Lianbo;
- Misra, Shrilekha;
- Walker, Brandi;
- Eathiraj, Sudharshan;
- Sampath, Deepa;
- Rogers, Kerry A.;
- Byrd, John C.;
- Woyach, Jennifer A.
Publication type:
Article
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01383-4
By:
- Kramer, Kim;
- Pandit-Taskar, Neeta;
- Kushner, Brian H.;
- Zanzonico, Pat;
- Humm, John L.;
- Tomlinson, Ursula;
- Donzelli, Maria;
- Wolden, Suzanne L.;
- Haque, Sophia;
- Dunkel, Ira;
- Souweidane, Mark M.;
- Greenfield, Jeffrey P.;
- Tickoo, Satish;
- Lewis, Jason S.;
- Lyashchenko, Serge K.;
- Carrasquillo, Jorge A.;
- Chu, Bae;
- Horan, Christopher;
- Larson, Steven M.;
- Cheung, Nai-Kong V.
Publication type:
Article
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01382-5
By:
- Lamers-Kok, Nina;
- Panella, Denise;
- Georgoudaki, Anna-Maria;
- Liu, Haiping;
- Özkazanc, Didem;
- Kučerová, Lucia;
- Duru, Adil Doganay;
- Spanholtz, Jan;
- Raimo, Monica
Publication type:
Article
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01376-3
By:
- Caruso, Simona;
- De Angelis, Biagio;
- Del Bufalo, Francesca;
- Ciccone, Roselia;
- Donsante, Samantha;
- Volpe, Gabriele;
- Manni, Simona;
- Guercio, Marika;
- Pezzella, Michele;
- Iaffaldano, Laura;
- Silvestris, Domenico Alessandro;
- Sinibaldi, Matilde;
- Di Cecca, Stefano;
- Pitisci, Angela;
- Velardi, Enrico;
- Merli, Pietro;
- Algeri, Mattia;
- Lodi, Mariachiara;
- Paganelli, Valeria;
- Serafini, Marta
Publication type:
Article
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01381-6
By:
- Li, Zhenyang;
- Zhou, Ye;
- Jia, Kaiwei;
- Yang, Yingyun;
- Zhang, Liyuan;
- Wang, Suyuan;
- Dong, Yue;
- Wang, Mu;
- Li, Yunhui;
- Lu, Shan;
- Zhang, Wannian;
- Zhang, Luxin;
- Fan, Yiwen;
- Zhang, Dingji;
- Li, Nan;
- Yu, Yizhi;
- Cao, Xuetao;
- Hou, Jin
Publication type:
Article
FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01378-1
By:
- Zhao, Shengbing;
- Wang, Shuling;
- Pan, Peng;
- Xia, Tian;
- Wang, Rundong;
- Cai, Quancai;
- Chang, Xin;
- Yang, Fan;
- Gu, Lun;
- He, Zixuan;
- Wu, Jiayi;
- Meng, Qianqian;
- Wang, Tongchang;
- Fang, Qiwen;
- Mou, Xiaomei;
- Yu, Honggang;
- Zheng, Jinghua;
- Bai, Cheng;
- Zou, Yingbin;
- Chen, Dongfeng
Publication type:
Article
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01358-5
By:
- Zhong, Xinyang;
- He, Xuefeng;
- Wang, Yaxian;
- Hu, Zijuan;
- Huang, Huixia;
- Zhao, Senlin;
- Wei, Ping;
- Li, Dawei
Publication type:
Article
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Published in:
2022
By:
- Jiang, Qian;
- Li, Zongru;
- Qin, Yazhen;
- Li, Weiming;
- Xu, Na;
- Liu, Bingcheng;
- Zhang, Yanli;
- Meng, Li;
- Zhu, Huanling;
- Du, Xin;
- Chen, Suning;
- Liang, Yang;
- Hu, Yu;
- Liu, Xiaoli;
- Song, Yongping;
- Men, Lichuang;
- Chen, Zi;
- Niu, Qian;
- Wang, Hengbang;
- Lu, Ming
Publication type:
Correction Notice
Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor.
Published in:
2022
By:
- Du, Xiaoling;
- Yang, Jilong;
- Ylipää, Antti;
- Zhu, Ze
Publication type:
Correction Notice
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01377-2
By:
- Spalato-Ceruso, Mariella;
- Bouteiller, Fanny;
- Guegan, Jean-Philippe;
- Toulmonde, Maud;
- Bessede, Alban;
- Kind, Michèle;
- Cousin, Sophie;
- Buy, Xavier;
- Palussiere, Jean;
- Le Loarer, François;
- Dadone-Montaudie, Berengere;
- Pulido, Marina;
- Italiano, Antoine
Publication type:
Article
Targeting ERRα promotes cytotoxic effects against acute myeloid leukemia through suppressing mitochondrial oxidative phosphorylation.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01372-7
By:
- Seo, Wonhyoung;
- Yoo, Seungyeul;
- Zhong, Yi;
- Lee, Sang-Hee;
- Woo, Soo-Yeon;
- Choi, Hee-Seon;
- Won, Minho;
- Roh, Taylor;
- Jeon, Sang Min;
- Kim, Kyeong Tae;
- Silwal, Prashanta;
- Lee, Min Joung;
- Heo, Jun Young;
- Lawlor, Nathan;
- Kim, Sup;
- Lee, Dongjun;
- Kim, Jin-Man;
- Song, Ik-Chan;
- Zhu, Jun;
- Jo, Eun-Kyeong
Publication type:
Article
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01361-w
By:
- Cortes, Jorge E.;
- Lin, Tara L.;
- Asubonteng, Kobby;
- Faderl, Stefan;
- Lancet, Jeffrey E.;
- Prebet, Thomas
Publication type:
Article
Drugging KRAS: current perspectives and state-of-art review.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01375-4
By:
- Parikh, Kaushal;
- Banna, Giuseppe;
- Liu, Stephen V.;
- Friedlaender, Alex;
- Desai, Aakash;
- Subbiah, Vivek;
- Addeo, Alfredo
Publication type:
Article
Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spectrometry.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01373-6
By:
- Fujiwara, Kenji;
- Shao, Yingkuan;
- Niu, Nan;
- Zhang, Tengyi;
- Herbst, Brian;
- Henderson, Mackenzie;
- Muth, Stephen;
- Zhang, Pingbo;
- Zheng, Lei
Publication type:
Article
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01364-7
By:
- Zhao, Binghao;
- Li, Huanzhang;
- Xia, Yu;
- Wang, Yaning;
- Wang, Yuekun;
- Shi, Yixin;
- Xing, Hao;
- Qu, Tian;
- Wang, Yu;
- Ma, Wenbin
Publication type:
Article
Correction: Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.
Published in:
2022
By:
- Qin, Rui;
- You, Feng‑Ming;
- Zhao, Qian;
- Xie, Xin;
- Peng, Cheng;
- Zhan, Gu;
- Han, Bo
Publication type:
Correction Notice
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01374-5
By:
- Byun, Ja Min;
- Min, Chang-Ki;
- Kim, Kihyun;
- Bang, Soo-Mee;
- Lee, Je-Jung;
- Kim, Jin Seok;
- Yoon, Sung-Soo;
- Koh, Youngil
Publication type:
Article
Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01370-9
By:
- Toulmonde, Maud;
- Cousin, Sophie;
- Kind, Michèle;
- Guegan, Jean-Philippe;
- Bessede, Alban;
- Le Loarer, Francois;
- Perret, Raul;
- Cantarel, Coralie;
- Bellera, Carine;
- Italiano, Antoine
Publication type:
Article
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01350-z
By:
- Qin, Rui;
- You, Feng-Ming;
- Zhao, Qian;
- Xie, Xin;
- Peng, Cheng;
- Zhan, Gu;
- Han, Bo
Publication type:
Article
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01240-4
By:
- Zhao, Ke;
- Lin, Ren;
- Fan, Zhiping;
- Chen, Xiaoyong;
- Wang, Yu;
- Huang, Fen;
- Xu, Na;
- Zhang, Xi;
- Zhang, Xin;
- Xuan, Li;
- Wang, Shunqing;
- Lin, Dongjun;
- Deng, Lan;
- Nie, Danian;
- Weng, Jianyu;
- Li, Yonghua;
- Zhang, Xiaohui;
- Li, Yuhua;
- Xiang, A. P.;
- Liu, Qifa
Publication type:
Article
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia.
Published in:
2022
By:
- Ma, Ya-Fang;
- Lu, Ying;
- Wu, Qian;
- Lou, Yin-Jun;
- Yang, Min;
- Xu, Jie-Yu;
- Sun, Cai-Hong;
- Mao, Li-Ping;
- Xu, Gai-Xiang;
- Li, Li;
- Huang, Jian;
- Wang, Huai-Yu;
- Lou, Li-Jiang;
- Meng, Hai-Tao;
- Qian, Jie-Jing;
- Yu, Wen-Juan;
- Wei, Ju-Ying;
- Li, Zhen-Yu;
- Zhu, Xue-Lu;
- Yan, Xiao-Yan
Publication type:
Letter
The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01360-x
By:
- Li, Shuangying;
- Wang, Liangliang;
- Wang, Yuanyuan;
- Zhang, Changyi;
- Hong, Zhenya;
- Han, Zhiqiang
Publication type:
Article
PARP1-MGMT complex underpins pathway crosstalk in O6-methylguanine repair.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01367-4
By:
- Cropper, Jodie D.;
- Alimbetov, Dauren S.;
- Brown, Kevin T. G.;
- Likhotvorik, Rostislav I.;
- Robles, Andrew J.;
- Guerra, James T.;
- He, Boxue;
- Chen, Yidong;
- Kwon, Youngho;
- Kurmasheva, Raushan T.
Publication type:
Article
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01357-6
By:
- Sorrentino, Carlo;
- D'Antonio, Luigi;
- Ciummo, Stefania Livia;
- Fieni, Cristiano;
- Landuzzi, Lorena;
- Ruzzi, Francesca;
- Vespa, Simone;
- Lanuti, Paola;
- Lotti, Lavinia Vittoria;
- Lollini, Pier Luigi;
- Di Carlo, Emma
Publication type:
Article
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01366-5
By:
- Beider, Katia;
- Voevoda-Dimenshtein, Valeria;
- Zoabi, Ali;
- Rosenberg, Evgenia;
- Magen, Hila;
- Ostrovsky, Olga;
- Shimoni, Avichai;
- Weiss, Lola;
- Abraham, Michal;
- Peled, Amnon;
- Nagler, Arnon
Publication type:
Article
The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01365-6
By:
- Wang, Hua;
- Zhou, Xiaowen;
- Li, Chenbei;
- Yan, Shuxiang;
- Feng, Chengyao;
- He, Jieyu;
- Li, Zhihong;
- Tu, Chao
Publication type:
Article
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01363-8
By:
- Yi, Ming;
- Niu, Mengke;
- Wu, Yuze;
- Ge, Hong;
- Jiao, Dechao;
- Zhu, Shuangli;
- Zhang, Jing;
- Yan, Yongxiang;
- Zhou, Pengfei;
- Chu, Qian;
- Wu, Kongming
Publication type:
Article
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01362-9
By:
- Wu, Qing;
- Qian, Wei;
- Sun, Xiaoli;
- Jiang, Shaojie
Publication type:
Article
Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01359-4
By:
- Liu, Tongyan;
- Han, Chencheng;
- Fang, Panqi;
- Ma, Zhifei;
- Wang, Xiaoxiao;
- Chen, Hao;
- Wang, Siwei;
- Meng, Fanchen;
- Wang, Cheng;
- Zhang, Erbao;
- Dong, Guozhang;
- Zhu, Hongyu;
- Yin, Wenda;
- Wang, Jie;
- Zuo, Xianglin;
- Qiu, Mantang;
- Wang, Jinke;
- Qian, Xu;
- Shen, Hongbing;
- Xu, Lin
Publication type:
Article
Gene and cell therapies in China: booming landscape under dual-track regulation.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01354-9
By:
- Yin, Chen;
- Gao, Jianchao;
- Li, Guanqiao;
- Hu, Hongxi;
- Zhou, Liyun;
- Lu, Shuang;
- Chen, Xiaoyuan
Publication type:
Article
Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01355-8
By:
- Wang, Siwei;
- Li, Ming;
- Zhang, Jingyuan;
- Xing, Peng;
- Wu, Min;
- Meng, Fancheng;
- Jiang, Feng;
- Wang, Jie;
- Bao, Hua;
- Huang, Jianfeng;
- Ren, Binhui;
- Yu, Mingfeng;
- Qiu, Ninglei;
- Li, Houhuai;
- Yuan, Fangliang;
- Zhang, Zhi;
- Jia, Hui;
- Lu, Xinxin;
- Zhang, Shuai;
- Wang, Xiaojun
Publication type:
Article
BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01353-w
By:
- Alu, Aqu;
- Lei, Hong;
- Han, Xuejiao;
- Wei, Yuquan;
- Wei, Xiawei
Publication type:
Article
Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01356-7
By:
- Chen, Tong;
- Liu, Yuanbo;
- Wang, Yang;
- Chang, Qing;
- Wu, Jinsong;
- Wang, Zhiliang;
- Geng, Daoying;
- Yu, Jin-Tai;
- Li, Yuan;
- Li, Xiao-Qiu;
- Chen, Hong;
- Zhuang, Dongxiao;
- Li, Jianyong;
- Wang, Bin;
- Jiang, Tao;
- Lyu, Lanting;
- Song, Yuqin;
- Qiu, Xiaoguang;
- Li, Wenbin;
- Lin, Song
Publication type:
Article
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01349-6
By:
- Shi, Xueke;
- Yang, Jin;
- Deng, Shuzhi;
- Xu, Hongdan;
- Wu, Deyang;
- Zeng, Qingxiang;
- Wang, Shimeng;
- Hu, Tao;
- Wu, Fanglong;
- Zhou, Hongmei
Publication type:
Article
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01352-x
By:
- Shaw, Gary;
- Cavalcante, Ludimila;
- Giles, Francis J.;
- Taylor, Alison
Publication type:
Article
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01350-z
By:
- Qin, Rui;
- You, Feng-Ming;
- Zhao, Qian;
- Xie, Xin;
- Peng, Cheng;
- Zhan, Gu;
- Han, Bo
Publication type:
Article
Liquid biopsy: current technology and clinical applications.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01351-y
By:
- Nikanjam, Mina;
- Kato, Shumei;
- Kurzrock, Razelle
Publication type:
Article
Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01320-5
By:
- Tian, Hailong;
- Zhang, Tingting;
- Qin, Siyuan;
- Huang, Zhao;
- Zhou, Li;
- Shi, Jiayan;
- Nice, Edouard C.;
- Xie, Na;
- Huang, Canhua;
- Shen, Zhisen
Publication type:
Article